Security Snapshot

BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN) Institutional Ownership

CUSIP: 09061G101

13F Institutional Holders and Ownership History from Q1 2014 to Q3 2026

13F reference period

Q3 2026

Institutions Reporting

434

Shares (Excl. Options)

133.01MFull value: 133,011,126 · shares · 30 Sep 2026

Price

$60.00

The headline uses the Q3 2026 reference period after its reporting deadline. Available reports may still be incomplete or amended.

Save this security page for your next review

Watchlists follow companies and investors, across their share classes. Bookmark this page to revisit this specific CUSIP and its quarterly holders. If you create an account from here, we will bring you back after verification.

Latest holder snapshot 5 signals
Portfolio coverage rank
0.02%
Share change
-1,444,862
Value change
-$76,335,444
Number of holders
434
Issuer context Names, identifiers, and filing context for this profile. 3 identity fields
Shares outstanding
193,733,090
SEC-reported price per share
$55.75
Insider filing price
$55.75
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Filing notes and source

Key facts

  • BMRN - BIOMARIN PHARMACEUTICAL INC - Common Stock is tracked under CUSIP 09061G101.
  • 434 institutions reported positions in Q3 2026.
  • 5 significant owners is listed from Schedule 13D/13G reporting.

Change

  • Holder count moved from 564 to 434 between Q2 2026 and Q3 2026.
  • SEC-reported value moved from
    $11.09BFull value: $11,092,536,334 · USD · 30 Jun 2026
    to
    $7.98BFull value: $7,975,324,452 · USD · 30 Sep 2026
    .

Research use

  • You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
  • 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.

Evidence

Source: SEC Form 13F

Latest holder context comes from 434 institutions filings for Q3 2026.

Open SEC evidence

Security key

09061G101

13F reference period

Q3 2026

13F holders

434

13D/G owners

5

CIK / CUSIP context first

13D/G owners

Significant owners

Large-stake holder rows connected to Schedule 13D/G evidence.

Rows
5
Security
BMRN
Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 10% +10% $1,063,400,931 +$99,491,309 19,373,309 +10% BlackRock, Inc. 31 Oct 2026
PRIMECAP MANAGEMENT CO/CA/ 8.2% $906,812,938 15,795,383 PRIMECAP MANAGEMENT CO/CA/ 30 Jun 2025
VANGUARD CAPITAL MANAGEMENT LLC 5.2% $571,295,741 10,113,219 Vanguard Capital Management 31 Mar 2026
Capital Research Global Investors 4.8% -29% $576,308,252 -$241,913,549 9,150,655 -30% Capital Research Global Investors 31 Mar 2025
VIKING GLOBAL INVESTORS LP 4.3% -35% $450,729,215 -$214,821,957 8,322,179 -32% VIKING GLOBAL INVESTORS LP 30 Sep 2025
As of 30 Sep 2026, 434 institutional investors reported holding
133.01MFull value: 133,011,126 · shares · 30 Sep 2026
shares of BIOMARIN PHARMACEUTICAL INC - Common Stock (BMRN). This represents 69% of the company’s total
193.73MFull value: 193,733,090 · shares · Stored outstanding share count
outstanding shares.

13F concentration

Top 25 institutional shareholders

Largest 13F positions for this security by reported shares and value.

Top holder share
52%
Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
PRIMECAP MANAGEMENT CO/CA/ 7.7% 14,988,996 0.56% $899,339,760
Dodge & Cox 7.5% 14,625,740 0.47% $877,544,400
VANGUARD CAPITAL MANAGEMENT LLC 4.5% 8,723,746 0.01% $523,424,760
VANGUARD PORTFOLIO MANAGEMENT LLC 4.3% 8,371,887 0.02% $502,313,220
STATE STREET CORP 4.3% 8,339,782 0.01% $500,386,920
VIKING GLOBAL INVESTORS LP 3.7% 7,173,173 1.3% $430,390,380
Deep Track Capital, LP 3.3% 6,374,395 6.4% $382,463,700
Vestal Point Capital, LP 2.9% 5,525,000 8.6% $331,500,000
DIMENSIONAL FUND ADVISORS LP 2.3% 4,398,881 0.05% $263,929,287
GEODE CAPITAL MANAGEMENT, LLC 1.9% 3,755,100 0.01% $225,362,334
Capital Research Global Investors 1.8% 3,558,680 0.03% $213,520,800
DEERFIELD MANAGEMENT COMPANY, L.P. 1% 2,025,146 1.9% $121,508,760
Swedbank AB 0.76% 1,476,737 0.08% $88,604,220
Assenagon Asset Management S.A. 0.69% 1,339,560 0.08% $80,373,600
VANGUARD FIDUCIARY TRUST CO 0.63% 1,227,243 0.02% $73,634,580
DNB ASSET MANAGEMENT AS 0.63% 1,217,281 0.19% $73,036,860
Jones Hill Capital LP 0.6% 1,171,859 12% $70,311,540
BANK OF AMERICA CORP /DE/ 0.57% 1,110,710 0% $66,642,600
Point72 Asset Management, L.P. 0.45% 878,931 0.08% $52,735,860
Hudson Bay Capital Management LP 0.39% 750,002 0.24% $45,000,120
ARGA Investment Management, LP 0.38% 737,541 1.1% $44,252,460
RENAISSANCE TECHNOLOGIES LLC 0.38% 727,771 0.06% $43,666,260
EDMOND DE ROTHSCHILD HOLDING S.A. 0.37% 712,880 0.52% $42,772,800
FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ 0.37% 712,052 0.22% $42,723,120
BOONE CAPITAL MANAGEMENT LLC 0.35% 671,998 11% $40,319,880

Quarter history

Institutional holders across reporting periods

Holder count, reported shares/value, and median price by quarter.

Periods
51
Headline period
Q3 2026
Rows shown
1-25 of 51
Period 13F Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2026 Q3 133,011,126 $7,975,324,452 -$76,335,444 $60.00 434
2026 Q2 193,922,794 $11,092,536,334 +$603,739,408 $57.22 564
2026 Q1 183,732,598 $10,372,926,863 -$364,504,564 $56.49 560
2025 Q4 187,901,687 $11,155,225,667 +$559,342,824 $59.43 535
2025 Q3 179,472,067 $9,720,162,187 -$257,275,980 $54.16 572
2025 Q2 184,517,274 $10,145,314,583 +$90,429,124 $54.97 576
2025 Q1 181,117,177 $12,795,609,480 -$83,582,224 $70.69 576
2024 Q4 183,186,403 $12,041,547,200 +$135,391,046 $65.73 536
2024 Q3 180,328,429 $12,672,555,041 -$377,350,661 $70.29 545
2024 Q2 184,765,128 $15,210,183,330 -$88,804,857 $82.33 555
2024 Q1 186,676,383 $16,305,278,098 +$52,133,744 $87.34 550
2023 Q4 185,955,477 $17,930,401,770 +$422,069,685 $96.42 540
2023 Q3 181,505,269 $16,056,450,996 +$288,283,093 $88.48 513
2023 Q2 178,653,463 $15,494,286,845 -$55,787,524 $86.68 548
2023 Q1 179,051,547 $17,400,388,762 -$352,972,540 $97.24 544
2022 Q4 182,911,512 $18,940,963,403 +$57,088,463 $103.49 570
2022 Q3 182,236,184 $15,455,338,348 +$265,782,383 $84.77 535
2022 Q2 179,167,298 $14,847,543,178 +$141,628,422 $82.87 525
2022 Q1 177,887,694 $13,719,376,304 +$56,012,733 $77.10 543
2021 Q4 177,134,050 $15,645,638,303 +$125,285,951 $88.35 539
2021 Q3 175,999,345 $13,600,848,412 +$49,734,828 $77.29 498
2021 Q2 176,035,547 $14,685,174,801 -$129,382,414 $83.44 510
2021 Q1 177,743,163 $13,419,458,431 -$323,613,922 $75.51 513
2020 Q4 182,409,125 $15,984,411,685 +$294,129,377 $87.69 519
2020 Q3 179,647,602 $13,663,308,058 -$318,133,163 $76.08 487
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .